Lung and gut microbiota profiling in intensive care unit patients: a prospective pilot study.

IF 3 3区 医学 Q2 INFECTIOUS DISEASES BMC Infectious Diseases Pub Date : 2025-04-05 DOI:10.1186/s12879-025-10825-6
Antonios Kritikos, Eric Bernasconi, Yangji Choi, Valentin Scherz, Jean-Luc Pagani, Gilbert Greub, Claire Bertelli, Benoit Guery
{"title":"Lung and gut microbiota profiling in intensive care unit patients: a prospective pilot study.","authors":"Antonios Kritikos, Eric Bernasconi, Yangji Choi, Valentin Scherz, Jean-Luc Pagani, Gilbert Greub, Claire Bertelli, Benoit Guery","doi":"10.1186/s12879-025-10825-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The gut and lung microbiomes play crucial roles in host defense and mayserve as predictive markersfor clinical outcomes in critically ill patients. Despite this, the simultaneous dynamics of lung and gut microbiomes during critical illness remain unclear. This study aims to assess the longitudinal changes in lung and gut microbiota among mechanically ventilated ICU patients with and without infection and to identify microbial features predictive of clinical outcomes, including the development of ventilator associated pneumonia (VAP).</p><p><strong>Methods: </strong>In this prospective observational study, we analyzed 73 endotracheal aspirates (ETA) and 93 rectal swabs collected from 38 ICU patients over multiple timepoints (intubation, infection onset, post-antibiotic, and extubation/discharge). Patients were categorized into three groups: (1) VAP, (2) other infections, and (3) uninfected controls. Lung and gut microbiota were characterized using 16S rRNA gene sequencing. Primary outcomes included microbial diversity and community composition; secondary outcomes included ICU length of stay and ventilator-free days.</p><p><strong>Results: </strong>Alpha diversity declined more significantly in infected patients than in controls during the ICU stay, with the most pronounced changes in lung microbiota. We found an enrichment of Enterobacteriaceae and other Proteobacteria in the lung microbiome of pneumonia patients, while the gut microbiota remained relatively stable. Relative abundances of key taxa such as Mogibacterium were associated with mechanical ventilation duration.</p><p><strong>Conclusions: </strong>This study reveals that distinct microbial patterns in both lung and gut microbiota are associated with infection and clinical outcomes in critically ill patients. Understanding these dynamics is crucial for developing targeted microbiota interventions, potentially improving outcomes such as VAP prevention and management.</p><p><strong>Trial registration: </strong>Ethics Committee of Canton Vaud, Switzerland (2017-01820).</p>","PeriodicalId":8981,"journal":{"name":"BMC Infectious Diseases","volume":"25 1","pages":"468"},"PeriodicalIF":3.0000,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972518/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12879-025-10825-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The gut and lung microbiomes play crucial roles in host defense and mayserve as predictive markersfor clinical outcomes in critically ill patients. Despite this, the simultaneous dynamics of lung and gut microbiomes during critical illness remain unclear. This study aims to assess the longitudinal changes in lung and gut microbiota among mechanically ventilated ICU patients with and without infection and to identify microbial features predictive of clinical outcomes, including the development of ventilator associated pneumonia (VAP).

Methods: In this prospective observational study, we analyzed 73 endotracheal aspirates (ETA) and 93 rectal swabs collected from 38 ICU patients over multiple timepoints (intubation, infection onset, post-antibiotic, and extubation/discharge). Patients were categorized into three groups: (1) VAP, (2) other infections, and (3) uninfected controls. Lung and gut microbiota were characterized using 16S rRNA gene sequencing. Primary outcomes included microbial diversity and community composition; secondary outcomes included ICU length of stay and ventilator-free days.

Results: Alpha diversity declined more significantly in infected patients than in controls during the ICU stay, with the most pronounced changes in lung microbiota. We found an enrichment of Enterobacteriaceae and other Proteobacteria in the lung microbiome of pneumonia patients, while the gut microbiota remained relatively stable. Relative abundances of key taxa such as Mogibacterium were associated with mechanical ventilation duration.

Conclusions: This study reveals that distinct microbial patterns in both lung and gut microbiota are associated with infection and clinical outcomes in critically ill patients. Understanding these dynamics is crucial for developing targeted microbiota interventions, potentially improving outcomes such as VAP prevention and management.

Trial registration: Ethics Committee of Canton Vaud, Switzerland (2017-01820).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症监护病房患者的肺和肠道微生物群分析:一项前瞻性试点研究。
背景:肠道和肺部微生物组在宿主防御中发挥着至关重要的作用,并可作为重症患者临床预后的预测指标。尽管如此,危重病人肺部和肠道微生物组的同时动态变化仍不清楚。本研究旨在评估机械通气 ICU 患者肺部和肠道微生物群的纵向变化,包括感染和未感染,并确定可预测临床结果(包括呼吸机相关肺炎(VAP)的发生)的微生物特征:在这项前瞻性观察研究中,我们分析了从 38 名重症监护病房患者身上采集的 73 份气管内吸痰液(ETA)和 93 份直肠拭子,这些拭子是在多个时间点(插管、感染开始、抗生素治疗后、拔管/出院)采集的。患者分为三组:(1) VAP,(2) 其他感染,(3) 未感染对照组。使用 16S rRNA 基因测序鉴定肺部和肠道微生物群。主要结果包括微生物多样性和群落组成;次要结果包括重症监护室住院时间和无呼吸机天数:结果:与对照组相比,感染患者在重症监护室住院期间的α多样性下降更为明显,其中肺部微生物群的变化最为明显。我们发现肺炎患者肺部微生物群中富含肠杆菌科和其他变形杆菌,而肠道微生物群则保持相对稳定。莫吉杆菌等关键类群的相对丰度与机械通气持续时间有关:这项研究揭示了肺部和肠道微生物群中不同的微生物模式与重症患者的感染和临床结果有关。了解这些动态变化对制定有针对性的微生物群干预措施至关重要,有可能改善VAP预防和管理等结果:瑞士沃州伦理委员会(2017-01820)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Infectious Diseases
BMC Infectious Diseases 医学-传染病学
CiteScore
6.50
自引率
0.00%
发文量
860
审稿时长
3.3 months
期刊介绍: BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Adherence to national pediatric antibiotic prescription guideline for pneumonia treatment of children 2-59 months: a retrospective chart review at a regional hospital in Rwanda. The impact of artificial intelligence on the prescribing, selection, resistance, and stewardship of antimicrobials: a scoping review. Epidemiological and antimicrobial resistance profile of catheter-associated and non-catheter urinary tract infections in trauma patients (2017-2024). Beta-lactam plus macrolide treatment versus beta-lactam monotherapy for community-acquired pneumonia: a propensity score analysis using data from a multicenter prospective cohort study. Global seroprevalence of Toxocara infection in children: a systematic review and meta-analysis of a neglected parasitic threat.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1